LISTSERV - LIBLICENSE-L Archives

LIBLICENSE-L Archives

LibLicense-L Discussion Forum

LIBLICENSE-L@LISTSERV.CRL.EDU

	LISTSERV Archives
	LIBLICENSE-L Home

	Log In
	Register

	Subscribe or Unsubscribe

	Search Archives

Options:	Use Forum View Use Monospaced Font Show Text Part by Default Show All Mail Headers
Message:	[<< First] [< Prev] [Next >] [Last >>]
Topic:	[<< First] [< Prev] [Next >] [Last >>]
Author:	[<< First] [< Prev] [Next >] [Last >>]

Subject:	Profile of Omics International in Bloomberg Businessweek
From:	LIBLICENSE <[log in to unmask]>
Reply To:	LibLicense-L Discussion Forum <[log in to unmask]>
Date:	Wed, 30 Aug 2017 01:39:30 -0400
Content-Type:	text/plain
Parts/Attachments:	text/plain (10 lines)

From: Ann Shumelda Okerson <[log in to unmask]>
Date: Wed, 30 Aug 2017 01:22:31 -0400

Medical jounals and fake news: an interesting article.

"With help from drug companies, Omics International is making millions
as it roils the scientific community with sketchy publications."

https://www.bloomberg.com/news/features/2017-08-29/medical-journals-have-a-fake-news-problem

ATOM RSS1 RSS2

LISTSERV.CRL.EDU